Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
BMC Cancer
|
January 15, 2024
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
Maximilian Mastall, Patrick Roth, Andrea Bink, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 27, 2025
Intracellular Formation of Synthetic Peptide Nanostructures Causes Mitochondrial Disruption and Cell Death in Tumor Spheroids
Sarah Chagri, Konrad Maxeiner, Maria J S A Silva, et al.
Multiple Sclerosis and Related Disorders
|
May 10, 2026
Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry
Stefania Iaquinto, Jannis Müller, Anke Salmen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
Caroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Neoplasia (New York, N.Y.)
|
November 4, 2024
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center
Jens von der Grün, Maiwand Ahmadsei, Isabel Breyer, et al.
JAMA Network Open
|
November 25, 2025
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma
Emilie Le Rhun, Debaleena Sain, Sara C Erridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2016
Reply to F. Felix et al and M.F. Fay et al
Caroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Oncotarget
|
June 9, 2016
Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells
Monica E Burgett, Justin D Lathia, Patrick Roth, et al.
Acta Neuropathologica
|
August 13, 2023
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival
Hans-Georg Wirsching, Jörg Felsberg, Michael Prummer, et al.
Oncotarget
|
February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
Michael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
BMC Cancer
|
January 15, 2024
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
Maximilian Mastall, Patrick Roth, Andrea Bink, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 27, 2025
Intracellular Formation of Synthetic Peptide Nanostructures Causes Mitochondrial Disruption and Cell Death in Tumor Spheroids
Sarah Chagri, Konrad Maxeiner, Maria J S A Silva, et al.
Multiple Sclerosis and Related Disorders
|
May 10, 2026
Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry
Stefania Iaquinto, Jannis Müller, Anke Salmen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
Caroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Neoplasia (New York, N.Y.)
|
November 4, 2024
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center
Jens von der Grün, Maiwand Ahmadsei, Isabel Breyer, et al.
JAMA Network Open
|
November 25, 2025
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma
Emilie Le Rhun, Debaleena Sain, Sara C Erridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2016
Reply to F. Felix et al and M.F. Fay et al
Caroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Oncotarget
|
June 9, 2016
Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells
Monica E Burgett, Justin D Lathia, Patrick Roth, et al.
Acta Neuropathologica
|
August 13, 2023
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival
Hans-Georg Wirsching, Jörg Felsberg, Michael Prummer, et al.
Oncotarget
|
February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
Michael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Page
of 23